In previous studies, gene promoter hypermethylation was associated with downregulation of tapasin, TAP1, TAP2, and LMP7 protein expression in esophageal squamous cell carcinoma, colon cancer, renal cancer, and melanoma. This evidence concerns the gene TAP2 and malignant colon neoplasm.